Recurrent Non-small Cell Lung Cancer Terminated Phase 1 Trials for Etoposide (DB00773)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01411098Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment